Clinical Trials Logo

Clinical Trial Summary

A randomized double-blind trial of oxytocin 5 u, carbetocin 100 µg and placebo with hemodynamic response as a primary outcome measure.


Clinical Trial Description

Healthy pregnant women sheduled for elective cesarean section. Invasive hemodynmaic monitoring with LiDCO Plus. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Effects of; Anesthesia, in Pregnancy

NCT number NCT00977769
Study type Interventional
Source Oslo University Hospital
Contact
Status Completed
Phase Phase 4
Start date November 2009
Completion date October 2011